Background/Aims: Helicobacter pylori cytotoxin-associated gene A (CagA) has been suggested to be involved in the inactivation of Runt-related transcription factor 3 (RUNX3), a known gastric carcinoma tumor suppressor gene. It remains unclear how H. pylori CagA initiates or maintains RUNX3 promoter methylation and inactivates its protein expression in gastric carcinoma. Methods: RUNX3 promoter methylation status, RUNX3 expression, and H. pylori CagA were investigated in 76 sample pairs of gastric carcinoma tissue. The patients' medical records were reviewed. The association between RUNX3 methylation or loss of RUNX3 expression and clinicopathologic variables according to H. pylori CagA status were investigated. Results: In gastric carcinoma patients with H. pylori CagA-positive infection, RUNX3 methylation did not show association with lymphatic invasion, venous invasion, and TNM stages. However RUNX3 methylation was observed more frequently in poorly differentiated adenocarcinoma and signet ring cell carcinoma (77.8% vs. 20.0%, p=0.023) in early stage. In gastric carcinoma patients with H. pylori CagA-positive infection, loss of RUNX3 expression did not show association with lymphatic invasion, venous invasion, and TNM stages. However loss of RUNX3 expression was observed more frequently in early gastric carcinoma than in advanced gastric carcinoma (84.2% vs. 75.0%, p=0.51), but this difference was not significant. Conclusions: In gastric carcinoma patients with H. pylori CagA-positive infection, RUNX3 methylation or loss of RUNX3 expression did not show correlation with lymphovascular invasion and TNM stages. In early gastric carcinoma patients with H. pylori CagA-positive infection, RUNX3 methylation was observed more in poorly differentiated adenocarcinoma and signet ring cell carcinoma. (Korean J Gastroenterol 2015;66:75-84) 
INTRODUCTION
Helicobacter pylori infection occurs in over 80% of all gastric carcinoma patients 1 with the bacterium classified as a group I human carcinogen for gastric adenocarcinoma. 2 H.
pylori infection is more associated with early gastric carcinoma patients than with non-neoplastic lesions or advanced gastric carcinoma patients. 3 Cytotoxin-associated gene A (CagA) is a significant virulence factor of H. pylori. 4 The CagA pathogenicity island also encodes a type IV secretion system
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where it causes disruption of the cell cytoskeleton, apical junction complex, and other intracellular activities. 5, 6 Infection with CagA-positive strains of H. pylori further increases the risk for non-cardiac gastric cancer as compared to the risk associated with H. pylori infection alone. 7 Since 2002, Runt-related transcription factor 3 (RUNX3)
has been recognized as a tumor suppressor gene for gastric cancer. 8 RUNX3 is frequently inactivated in gastric cancer through the following four mechanisms: aberrant methylation of the gene's promoter, protein mislocalization, histone modification, and hemizygous deletion. 8, 9 RUNX3 inactivation by methylation occurs at the CpG site by the addition of a methyl group, subsequently converting to 5-methylcytosine.
In a recent meta-analysis, an association between methylation of the RUNX3 promoter and gastric carcinoma was reported, confirming the role of RUNX3 as a tumor suppressor gene. 10 The same study found that the RUNX3 promoter methylation status was not correlated with either TNM staging or lymphatic and venous invasion. 10 However, RUNX3 inactivation by protein mislocalization is a marker for the loss of tumor suppression and impairment of transforming growth factor- signaling in gastric carcinoma. 9 The relationship between H. pylori CagA and RUNX3 methylation or protein mislocalization has only recently been elucidated in early gastric cancer tissue. H. pylori 16S RNA may be an independent risk factor for RUNX3 methylation in patients with early gastric carcinoma. 11 The protein mislocalization of RUNX3, because of which it moves from the nucleus to the cytoplasm, may be a major mechanism underlying the association between H. pylori infection and gastric carcinoma development. 9 RUNX3 inactivation occurs early during the progression to malignancy. 10, 12, 13 In the current study, we investigated the association be- 
Methylation-specific PCR for RUNX3
Methylation-specific PCR (MSP) was performed using the bisulfite-modified DNA templates obtained from the endoscopic specimen of human gastric carcinoma tissues. Endoscopic samples from neoplastic and non-neoplastic gastric mucosa were used. The macroscopic non-neoplastic gastric mucosa was defined to be at least 5 cm away from the neoplastic gastric mucosa. Genomic DNA was obtained by proteinase K digestion and extraction using the LaboPass TM Tissue
Mini kit (COSMO Genetech, Seoul, Korea). The genomic DNA concentration and purity were measured using a spectrophotometer (purity=1.7−1.9 at 260/280 nm) and the DNA was treated with sodium bisulfite according to the manufacturer's instructions. Thereafter, 2 g of the genomic DNA was denatured with 2 M NaOH and modified with 3 M sodium bi- 
Immunohistochemical staining for RUNX3
Immunohistochemical analysis was performed using the Bond TM Polymer DAB Detection Kit (Leica Microsystems, Weltzar, Germany) and Bond-X automated immunohistochemistry slide staining system (Leica Microsystems).
Formalin-fixed and paraffin-embedded serial sections using four micron-thick samples were deparaffinized and dehydrated. The sections were heated in citrate buffer (pH 6.0, 10 mM) in a microwave for 20 min for retrieval of antigens.
Endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide for 10 min followed by incubation with the primary antibodies: mouse monoclonal anti-RUNX3 antibody
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Statistical analysis
The relationship between RUNX3 methylation status and clinicopathological variables was investigated according to Values are presented as mean±SD or n (%). W/D, tubular adenocarcinoma, well differentiated; M/D, tubular adenocarcinoma moderately differentiated; P/D, tubular adenocarcinoma, poorly differentiated; SRC, signet ring cell cancer. 
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Three cases of cytoplasmic mislocalization were observed in two patients with early gastric cancer and one patient with advanced gastric cancer (Fig. 2D) . Of the 31 patients with RUNX3 methylation, 26 (83.9%) had a loss of RUNX3 expression, and 31 (68.9%) of the 45 patients without RUNX3
methylation had a loss of RUNX3 expression (p=0.14).
Loss of nuclear RUNX3 expression (negative expression)
did not show correlation with histological differentiation, lymphatic invasion, venous invasion, T stage, N stage, distant (Table 5 ). In patients with H. pylori CagA infection, loss of RUNX3 expression in early gastric carcinoma patients was more than that in advanced gastric carcinoma patients (84.2% [16/19] vs.
75.0% [27/36] ) (p=0.51), but the differences were not significant.
DISCUSSION
In our study, in gastric carcinoma patients with CagA-positive H. pylori infection, RUNX3 methylation status or loss of RUNX3 expression was not found to show association with lymphatic invasion, venous invasion, or TNM stages. However, RUNX3 methylation is more significantly found in poorly differentiated adenocarcinoma and signet ring cell carcinoma in the early stages. Loss of RUNX3 expression was found more often in early gastric carcinoma than in advanced gastric carcinoma.
The RUNX family includes RUNX1, RUNX2, and RUNX3, with each member exerting different regulatory functions in intracellular processes. 17 RUNX3, with its encoding gene located on chromosome 1p36, is involved in gastric epithelial growth 8, 12 and T-cell differentiation. 18 Mislocalization of RUNX3 leading to its activation has been reported to result in a loss of nuclear RUNX3 expression in 44% of gastric carcinoma cases and cytoplasmic mislocalization in 38% of cases. 9 Inactivation of RUNX3 by promoter methylation was reported in 45-65% of all gastric carcinomas. 10, 19, 20 Most reported cases of gastric carcinoma in East Asia are associated with CagA-positive H. pylori infection. In comparison to the Western CagA-positive H. pylori strain, CagA in East Asia more often causes severe gastric mucosal inflammation and is associated with severe atrophic gastritis and gastric adenocarcinoma. 21, 22 In a meta-analysis, the percentage of patients sero-positive for H. pylori CagA in East Asia varied from 61% to 96.6% of the total number of gastric cancer patients. 23 This positive result included both current and past infections. In another meta-analysis, the rate of CagA infection, determined using PCR techniques, varied from 79% to 100% in gastric cancer. 24 The rate of the East-Asian type H. pylori CagA was 83%. 24 In this study, the 32 In a phosphorylation-independent manner, H. pylori CagA directly induce the ubiquitination and degradation of the RUNX3 protein in the cytoplasm of gastric carcinoma cells. 35 In addition, RUNX3 protein mislocalization or loss of nuclear RUNX3 expression is a known mechanism of RUNX3 inactivation in early-stage carcinoma in both the colon and the breast. 36, 37 In this study, cytoplasmic mislocalization was observed in three cases. Cytoplasmic mislocalization may be a mecha- 
